Apnimed, Inc.
NASDAQ:APMDBiotechnology
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Accounts Payables history
Currency unavailable · from the cash flow
No Accounts Payables data reported for this period type.
Accounts Payables vs competitors
How APMD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $22.26M USD | -227.8% | — | 2.5% | |
| LTM Mar 2026 | €2.84M EUR | — | — | 17.4% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | -227.8% | — | 9.9% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.